Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
Publication

Publications

State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections

Title
State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
Type
Another Publication in an International Scientific Journal
Year
2020
Authors
Cano, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ettcheto, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Espina, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopez Machado, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cajal, Y
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Rabanal, F
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sanchez Lopez, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Camins, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Garcia, ML
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Souto, EB
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 18
ISSN: 1477-3155
Publisher: Springer Nature
Indexing
Scientific classification
CORDIS: Health sciences
Other information
Authenticus ID: P-00T-0C3
Abstract (EN): Infectious diseases kill over 17 million people a year, among which bacterial infections stand out. From all the bacterial infections, tuberculosis, diarrhoea, meningitis, pneumonia, sexual transmission diseases and nosocomial infections are the most severe bacterial infections, which affect millions of people worldwide. Moreover, the indiscriminate use of antibiotic drugs in the last decades has triggered an increasing multiple resistance towards these drugs, which represent a serious global socioeconomic and public health risk. It is estimated that 33,000 and 35,000 people die yearly in Europe and the United States, respectively, as a direct result of antimicrobial resistance. For all these reasons, there is an emerging need to find novel alternatives to overcome these issues and reduced the morbidity and mortality associated to bacterial infectious diseases. In that sense, nanotechnological approaches, especially smart polymeric nanoparticles, has wrought a revolution in this field, providing an innovative therapeutic alternative able to improve the limitations encountered in available treatments and capable to be effective by theirselves. In this review, we examine the current status of most dangerous human infections, together with an in-depth discussion of the role of nanomedicine to overcome the current disadvantages, and specifically the most recent and innovative studies involving polymeric nanoparticles against most common bacterial infections of the human body.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 24
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer's disease: from current to future challenges (2021)
Another Publication in an International Scientific Journal
Cano, A; Turowski, P; Ettcheto, M; Duskey, JT; Tosi, G; Sanchez Lopez, E; Garcia, ML; Camins, A; Souto, EB; Ruiz, A; Marquie, M; Boada, M
How could nanobiotechnology improve treatment outcomes of anti-TNF-alpha therapy in inflammatory bowel disease? Current knowledge, future directions (2021)
Another Publication in an International Scientific Journal
Eder, P; Zielinska, A; Karczewski, J; Dobrowolska, A; Slomski, R; Souto, EB
Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior (2018)
Article in International Scientific Journal
Catarina Santos; Suzy Turiel; Pedro Sousa Gomes; Elísio Costa; Alice Santos‑Silva; Paulo Quadros; José Duarte; Sílvia Battistuzzo; Maria Helena Fernandes
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer¿s disease: in vitro and in vivo characterization (2018)
Article in International Scientific Journal
Sánchez-López, E; Ettcheto, M; Egea, MA; Espina, M; Cano, A; Calpena, AC; Camins, A; Carmona, N; Silva, AM; Souto, EB; García, ML
Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E (2016)
Article in International Scientific Journal
Neves, AR; Queiroz, JF; Salette Reis
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-14 at 22:54:21 | Privacy Policy | Personal Data Protection Policy | Whistleblowing